Suchergebnisse - "Balar, Arjun V"

PubPharm (9)

1

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer : A Multicenter, Single-Arm, Phase II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Funt, S. | Lattanzi, M. | Whiting, K. | +36

CommentIn: J Clin Oncol. 2022 Aug 10;40(23):2656. - PMID 35609220

2

Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma

enthalten in: European urology | 2020

von Teo, M. | Mota, J. | Whiting, K. | +14

ErratumIn: Eur Urol. 2021 Feb 9;:. - PMID 33579575

3

Outcomes With First-line PD-1/PD-L1 Inhibition in Advanced Urothelial Cancer : A Single Institution Experience

enthalten in: Clinical genitourinary cancer | 2020

von Hsu, M. | Xia, Y. | Troxel, A. | +5

4

PD-1/PD-L1 Combinations in Advanced Urothelial Cancer : Rationale and Current Clinical Trials

enthalten in: Clinical genitourinary cancer | 2019

von Hsu, M. | Balar, A.

5

Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer

enthalten in: The oncologist | 2019

von Osterman, C. | Babu, D. | Geynisman, D. | +13

CommentIn: Oncologist. 2019 May;24(5):580-583. - PMID 30926675

6

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Iyer, G. | Balar, A. | Milowsky, M. | +28

CommentIn: Eur Urol. 2019 Dec;76(6):870-871. - PMID 31351667

7

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy : a single-arm, multicentre, phase 2 trial

enthalten in: Lancet (London, England) | 2016

von Rosenberg, J. | Hoffman-Censits, J. | Powles, T. | +28

CommentIn: Lancet. 2016 May 7;387(10031):1881-2. - PMID 26952549

8

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Iyer, G. | Al-Ahmadie, H. | Schultz, N. | +18

9

Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Balar, A. | Apolo, A. | Ostrovnaya, I. | +8

1
[1]